Evidence map›Paper›PMID 39968069›Full record

ArticleFrontiers in oncology2025

Case report: A rare case of a long-term survivor of glioblastoma who underwent two courses of hypofractionated radiotherapy as part of her care.

Midhad Mrvoljak, Shubhendu Mishra, Liam Chen, Elizabeth Neil, Eric Ehler, Stephanie Terezakis, Lindsey Sloan

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Midhad MrvoljakCollege of Osteopathic Medicine, Des Moines University, Des Moines, IA, United States.
Shubhendu MishraDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, United States.
Liam ChenMasonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
Elizabeth NeilMasonic Cancer Center, University of Minnesota, Minneapolis, MN, United States.
Eric EhlerDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, United States.
Stephanie TerezakisDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, United States.
Lindsey SloanDepartment of Radiation Oncology, University of Minnesota Medical School, Minneapolis, MN, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glioblastoma (GB) is a primary brain tumor that is lethal and challenging to treat. The 3-year overall survival (OS) of patients with this diagnosis has stayed the same since 2005. The patient is a 75-year-old woman who presented with progressive aphasia and was diagnosed with GB (WHO grade 4, IDH1/IDH2 wild type, ATRX intact, p53 and PTEN mutant, BRAF non-mutated, O

Indexed as

case reportglioblastomahypofractionated radiotherapylong-term survivorreirradiation

Identifiers

PMID39968069
PMCPMC11832352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.